{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:49:15Z","timestamp":1793674155418,"version":"4.5.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T00:00:00Z","timestamp":1549843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T00:00:00Z","timestamp":1549843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000093","name":"U.S. Department of Health & Human Services | NIH | Center for Information Technology","doi-asserted-by":"publisher","award":["DA038598"],"award-info":[{"award-number":["DA038598"]}],"id":[{"id":"10.13039\/100000093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Abnormal levels of dopamine (DA) are thought to contribute to several neurological and psychiatric disorders including drug addiction. Extracellular DA levels are regulated primarily via reuptake by the DA transporter (DAT). Amphetamine, a potent psychostimulant, increases extracellular DA by inducing efflux through DAT. Recently, we discovered that G protein \u03b2\u03b3 subunits (G\u03b2\u03b3) interact with DAT, and that in vitro activation of G\u03b2\u03b3 promotes DAT-mediated efflux. Here, we investigated the role of G\u03b2\u03b3 in the actions of amphetamine in DA neurons in culture, ex vivo nucleus accumbens (NAc), and freely moving rats. Activation of G\u03b2\u03b3 with the peptide myr-Ser-Ile-Arg-Lys-Ala-Leu-Asn-Ile-Leu-Gly-Tyr-Pro-Asp-Tyr-Asp (mSIRK) in the NAc potentiated amphetamine-induced hyperlocomotion, but not cocaine-induced hyperlocomotion, and systemic or intra-accumbal administration of the G\u03b2\u03b3 inhibitor gallein attenuated amphetamine-induced, but not cocaine-induced hyperlocomotion. Infusion into the NAc of a TAT-fused peptide that targets the G\u03b2\u03b3-binding site on DAT (TAT-DATct1) also attenuated amphetamine-induced but not cocaine-induced hyperlocomotion. In DA neurons in culture, inhibition of G\u03b2\u03b3 with gallein or blockade of the G\u03b2\u03b3\u2013DAT interaction with the TAT-DATct1 peptide decreased amphetamine-induced DA efflux. Furthermore, activation of G\u03b2\u03b3 with mSIRK potentiated and inhibition of G\u03b2\u03b3 with gallein reduced amphetamine-induced increases of extracellular DA in the NAc in vitro and in freely moving rats. Finally, systemic or intra-accumbal inhibition of G\u03b2\u03b3 with gallein blocked the development of amphetamine-induced, but not cocaine-induced place preference. Collectively, these results suggest that interaction between G\u03b2\u03b3 and DAT plays a critical role in the actions of amphetamine and presents a novel target for modulating the actions of amphetamine in vivo.<\/jats:p>","DOI":"10.1038\/s41398-019-0387-8","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T17:04:17Z","timestamp":1549904657000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["G protein \u03b2\u03b3 subunits play a critical role in the actions of amphetamine"],"prefix":"10.1038","volume":"9","author":[{"given":"J. C.","family":"Mauna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. S.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1542-0660","authenticated-orcid":false,"given":"J. A.","family":"Pino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. M.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. R.","family":"DeChellis-Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. D.","family":"Bassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Garcia-Olivares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. G.","family":"Amara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. G.","family":"Guajardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Sotomayor-Zarate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5816-9763","authenticated-orcid":false,"given":"M.","family":"Terminel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Casta\u00f1eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Vergara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Baust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Thiels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. E.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,11]]},"reference":[{"key":"387_CR1","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nrn1406","volume":"5","author":"RA Wise","year":"2004","unstructured":"Wise, R. A. Dopamine, learning and motivation. Nat. Rev. Neurosci. 5, 483\u2013494 (2004).","journal-title":"Nat. Rev. Neurosci."},{"key":"387_CR2","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.tins.2007.03.002","volume":"30","author":"SD Iversen","year":"2007","unstructured":"Iversen, S. D. & Iversen, L. L. Dopamine: 50 years in perspective. Trends Neurosci. 30, 188\u2013193 (2007).","journal-title":"Trends Neurosci."},{"key":"387_CR3","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neuint.2013.10.016","volume":"73","author":"R Gowrishankar","year":"2014","unstructured":"Gowrishankar, R., Hahn, M. K. & Blakely, R. D. Good riddance to dopamine: roles for the dopamine transporter in synaptic function and dopamine-associated brain disorders. Neurochem. Int. 73, 42\u201348 (2014).","journal-title":"Neurochem. Int."},{"key":"387_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-385506-0.00001-6","volume":"98","author":"Z Lin","year":"2011","unstructured":"Lin, Z. et al. Monoamine transporters: vulnerable and vital doorkeepers. Prog. Mol. Biol. Transl. Sci. 98, 1\u201346 (2011).","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"387_CR5","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1124\/pr.114.010397","volume":"67","author":"CL German","year":"2015","unstructured":"German, C. L., Baladi, M. G., McFadden, L. M., Hanson, G. R. & Fleckenstein, A. E. Regulation of the dopamine transporter and vesicular monoamine transporters: pharmacological target and implications for disease. Pharmacol. Rev. 67, 1005\u20131024 (2015).","journal-title":"Pharmacol. Rev."},{"key":"387_CR6","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/19208","volume":"398","author":"TW Robbins","year":"1999","unstructured":"Robbins, T. W. & Everitt, B. J. Drug addiction: bad habits add up. Nature 398, 567\u2013570 (1999).","journal-title":"Nature"},{"key":"387_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1196\/annals.1441.031","volume":"1141","author":"S Berman","year":"2008","unstructured":"Berman, S., O\u2019Neill, J., Fears, S., Bartzokis, G. & London, E. D. Abuse of amphetamines and structural abnormalities in the brain. Ann. N. Y. Acad. Sci. 1141, 195\u2013220 (2008).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"387_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1515\/bc.2011.016","volume":"392","author":"T Steinkellner","year":"2011","unstructured":"Steinkellner, T., Freissmuth, M., Sitte, H. H. & Montgomery, T. The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, \u201cEcstasy\u201d), methamphetamine and D-amphetamine. Biol. Chem. 392, 103\u2013115 (2011).","journal-title":"Biol. Chem."},{"key":"387_CR9","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.1073\/pnas.95.7.4029","volume":"95","author":"SR Jones","year":"1998","unstructured":"Jones, S. R. et al. Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc. Natl Acad. Sci. USA 95, 4029\u20134034 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"387_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrn1008","volume":"4","author":"GE Torres","year":"2003","unstructured":"Torres, G. E., Gainetdinov, R. R. & Caron, M. G. Plasma membrane monoamine transporter: structure, regulation and function. Nat. Rev. Neurosci. 4, 13\u201325 (2003).","journal-title":"Nat. Rev. Neurosci."},{"key":"387_CR11","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/j.1471-4159.2011.07335.x","volume":"118","author":"V Leviel","year":"2011","unstructured":"Leviel, V. Dopamine release mediated by the dopamine transporter, facts and consequences. J. Neurochem. 118, 475\u2013489 (2011).","journal-title":"J. Neurochem."},{"key":"387_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejphar.2003.08.065","volume":"479","author":"KM Kahlig","year":"2003","unstructured":"Kahlig, K. M. & Galli, A. Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine. Eur. J. Pharmacol. 479, 153\u2013158 (2003).","journal-title":"Eur. J. Pharmacol."},{"key":"387_CR13","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.bcp.2007.08.003","volume":"75","author":"LL Howell","year":"2008","unstructured":"Howell, L. L. & Kimmel, H. L. Monoamine transporters and psychostimulant addiction. Biochem. Pharmacol. 75, 196\u2013217 (2008).","journal-title":"Biochem. Pharmacol."},{"key":"387_CR14","first-page":"266","volume":"289","author":"NR Zahniser","year":"1999","unstructured":"Zahniser, N. R., Larson, G. A. & Gerhardt, G. A. In vivo dopamine clearance rate in rat striatum: regulation by extracellular dopamine concentration and dopamine transporter inhibitors. J. Pharmacol. Exp. Ther. 289, 266\u2013277 (1999).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"387_CR15","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.1523\/JNEUROSCI.15-05-04102.1995","volume":"15","author":"D Sulzer","year":"1995","unstructured":"Sulzer, D. et al. Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J. Neurosci. 15, 4102\u20134108 (1995).","journal-title":"J. Neurosci."},{"key":"387_CR16","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1073\/pnas.0407737102","volume":"102","author":"KM Kahlig","year":"2005","unstructured":"Kahlig, K. M. et al. Amphetamine induces dopamine efflux through a dopamine transporter channel. Proc. Natl Acad. Sci. USA 102, 3495\u20133500 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"387_CR17","doi-asserted-by":"publisher","first-page":"10914","DOI":"10.1074\/jbc.M413887200","volume":"280","author":"LA Johnson","year":"2005","unstructured":"Johnson, L. A., Guptaroy, B., Lund, D., Shamban, S. & Gnegy, M. E. Regulation of amphetamine-stimulated dopamine efflux by protein kinase C beta. J. Biol. Chem. 280, 10914\u201310919 (2005).","journal-title":"J. Biol. Chem."},{"key":"387_CR18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.neuron.2006.06.028","volume":"51","author":"JU Fog","year":"2006","unstructured":"Fog, J. U. et al. Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport. Neuron 51, 417\u2013429 (2006).","journal-title":"Neuron"},{"key":"387_CR19","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1124\/mol.108.048447","volume":"74","author":"F Binda","year":"2008","unstructured":"Binda, F. et al. Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux. Mol. Pharmacol. 74, 1101\u20131108 (2008).","journal-title":"Mol. Pharmacol."},{"key":"387_CR20","first-page":"148","volume":"32","author":"JC Chen","year":"2009","unstructured":"Chen, J. C., Chen, P. C. & Chiang, Y. C. Molecular mechanisms of psychostimulant addiction. Chang Gung Med J. 32, 148\u2013154 (2009).","journal-title":"Chang Gung Med J."},{"key":"387_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s12035-009-8053-4","volume":"39","author":"SD Robertson","year":"2009","unstructured":"Robertson, S. D., Matthies, H. J. & Galli, A. A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters. Mol. Neurobiol. 39, 73\u201380 (2009).","journal-title":"Mol. Neurobiol."},{"key":"387_CR22","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1038\/npp.2017.95","volume":"42","author":"C Carpenter","year":"2017","unstructured":"Carpenter, C. et al. Direct and systemic administration of a CNS-permeant Tamoxifen analog reduces amphetamine-induced dopamine release and reinforcing effects. Neuropsychopharmacology 42, 1940\u20131949 (2017).","journal-title":"Neuropsychopharmacology"},{"key":"387_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059788","volume":"8","author":"J Garcia-Olivares","year":"2013","unstructured":"Garcia-Olivares, J. et al. Inhibition of dopamine transporter activity by G protein \u03b2\u03b3 subunits. PLoS ONE 8, e59788 (2013).","journal-title":"PLoS ONE"},{"key":"387_CR24","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1038\/mp.2017.176","volume":"22","author":"J Garcia-Olivares","year":"2017","unstructured":"Garcia-Olivares, J. et al. G\u03b2\u03b3subunit activation promotes dopamine efflux through the dopamine transporter. Mol. Psychiatry 22, 1673\u20131679 (2017).","journal-title":"Mol. Psychiatry"},{"key":"387_CR25","first-page":"101","volume":"94","author":"LH Gold","year":"1989","unstructured":"Gold, L. H., Geyer, M. A. & Koob, G. F. Neurochemical mechanisms involved in behavioral effects of amphetamines and related designer drugs. NIDA Res. Monogr. 94, 101\u2013126 (1989).","journal-title":"NIDA Res. Monogr."},{"key":"387_CR26","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/(SICI)1098-2396(199808)29:4<310::AID-SYN3>3.0.CO;2-8","volume":"29","author":"C Heidbreder","year":"1998","unstructured":"Heidbreder, C. & Feldon, J. Amphetamine-induced neurochemical and locomotor response are expressed differentially across the anteroposterior axis of the core and shell subterritories of the nucleus accumbens. Synapse 29, 310\u2013322 (1998).","journal-title":"Synapse"},{"key":"387_CR27","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/0006-8993(87)91416-8","volume":"401","author":"T Sharp","year":"1987","unstructured":"Sharp, T., Zetterstr\u00f6m, T., Ljungberg, T. & Ungerstedt, U. A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis. Brain Res. 401, 322\u2013330 (1987).","journal-title":"Brain Res."},{"key":"387_CR28","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1177\/0269881113482532","volume":"27","author":"DJ Heal","year":"2013","unstructured":"Heal, D. J., Smith, S. L., Gosden, J. & Nutt, D. J. Amphetamine, past and present\u2014a pharmacological and clinical perspective. J. Psychopharmacol. 27, 479\u2013496 (2013).","journal-title":"J. Psychopharmacol."},{"key":"387_CR29","doi-asserted-by":"publisher","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","volume":"85","author":"G Di Chiara","year":"1988","unstructured":"Di Chiara, G. & Imperato, A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl Acad. Sci. USA 85, 5274\u20135278 (1988).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"387_CR30","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/BF02245141","volume":"107","author":"G Laviola","year":"1992","unstructured":"Laviola, G., Dell\u2019Omo, G., Alleva, E. & Bignami, G. Ontogeny of cocaine hyperactivity and conditioned place preference in mice. Psychopharmacology 107, 221\u2013228 (1992).","journal-title":"Psychopharmacology"},{"key":"387_CR31","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1523\/JNEUROSCI.2383-07.2008","volume":"28","author":"MW Shiflett","year":"2008","unstructured":"Shiflett, M. W. et al. Cue-elicited reward-seeking requires extracellular signal-regulated kinase activation in the nucleus accumbens. J. Neurosci. 28, 1434\u20131443 (2008).","journal-title":"J. Neurosci."},{"key":"387_CR32","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1101\/lm.035113.114","volume":"21","author":"EK Kirschmann","year":"2014","unstructured":"Kirschmann, E. K. et al. Appetitive cue-evoked ERK signaling in the nucleus accumbens requires NMDA and D1 dopamine receptor activation and regulates CREB phosphorylation. Learn Mem. 21, 606\u2013615 (2014).","journal-title":"Learn Mem."},{"key":"387_CR33","doi-asserted-by":"publisher","first-page":"19634","DOI":"10.1074\/jbc.M300052200","volume":"278","author":"F Goubaeva","year":"2003","unstructured":"Goubaeva, F. et al. Stimulation of cellular signaling and G protein subunit dissociation by G protein betagamma subunit-binding peptides. J. Biol. Chem. 278, 19634\u201319641 (2003).","journal-title":"J. Biol. Chem."},{"key":"387_CR34","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1007\/s00018-008-8006-5","volume":"65","author":"AV Smrcka","year":"2008","unstructured":"Smrcka, A. V. G protein \u03b2\u03b3 subunits: central mediators of G protein-coupled receptor signaling. Cell Mol. Life Sci. 65, 2191\u20132214 (2008).","journal-title":"Cell Mol. Life Sci."},{"key":"387_CR35","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00005-013-0230-5","volume":"61","author":"Y Wang","year":"2013","unstructured":"Wang, Y., Li, Y. & Shi, G. The regulating function of heterotrimeric G proteins in the immune system. Arch. Immunol. Ther. Exp. (Warsz.) 61, 309\u2013319 (2013).","journal-title":"Arch. Immunol. Ther. Exp. (Warsz.)"},{"key":"387_CR36","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1124\/mol.107.041780","volume":"73","author":"DM Lehmann","year":"2008","unstructured":"Lehmann, D. M., Seneviratne, A. M. & Smrcka, A. V. Small molecule disruption of G protein beta gamma subunit signaling inhibits neutrophil chemotaxis and inflammation. Mol. Pharmacol. 73, 410\u2013418 (2008).","journal-title":"Mol. Pharmacol."},{"key":"387_CR37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jchemneu.2016.10.004","volume":"83\u201384","author":"JD Foster","year":"2017","unstructured":"Foster, J. D. & Vaughan, R. A. Phosphorylation mechanisms in dopamine transporter regulation. J. Chem. Neuroanat. 83\u201384, 10\u201318 (2017).","journal-title":"J. Chem. Neuroanat."},{"key":"387_CR38","doi-asserted-by":"publisher","first-page":"E78","DOI":"10.1371\/journal.pbio.0020078","volume":"2","author":"H Khoshbouei","year":"2004","unstructured":"Khoshbouei, H. et al. N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux. PLoS Biol. 2, E78 (2004).","journal-title":"PLoS Biol."},{"key":"387_CR39","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1038\/npp.2014.124","volume":"39","author":"T Steinkellner","year":"2014","unstructured":"Steinkellner, T. et al. In vivo amphetamine action is contingent on \u03b1CaMKII. Neuropsychopharmacology 39, 2681\u20132693 (2014).","journal-title":"Neuropsychopharmacology"},{"key":"387_CR40","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nchembio.1545","volume":"10","author":"PJ Hamilton","year":"2014","unstructured":"Hamilton, P. J. et al. PIP2 regulates psychostimulant behaviors through its interaction with a membrane protein. Nat. Chem. Biol. 10, 582\u2013589 (2014).","journal-title":"Nat. Chem. Biol."},{"key":"387_CR41","doi-asserted-by":"publisher","first-page":"11642","DOI":"10.1073\/pnas.1220552110","volume":"110","author":"F Buchmayer","year":"2013","unstructured":"Buchmayer, F. et al. Amphetamine actions at the serotonin transporter rely on the availability of phosphatidylinositol-4,5-bisphosphate. Proc. Natl Acad. Sci. USA 110, 11642\u201311647 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"387_CR42","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/35882","volume":"391","author":"CL Huang","year":"1998","unstructured":"Huang, C. L., Feng, S. & Hilgemann, D. W. Direct activation of inward rectifier potassium channels by PIP2 and its stabilization by Gbetagamma. Nature 391, 803\u2013806 (1998).","journal-title":"Nature"},{"key":"387_CR43","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1073\/pnas.96.10.5820","volume":"96","author":"HH Liou","year":"1999","unstructured":"Liou, H. H., Zhou, S. S. & Huang, C. L. Regulation of ROMK1 channel by protein kinase A via a phosphatidylinositol 4,5-bisphosphate-dependent mechanism. Proc. Natl Acad. Sci. USA 96, 5820\u20135825 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"387_CR44","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature10370","volume":"477","author":"SB Hansen","year":"2011","unstructured":"Hansen, S. B., Tao, X. & MacKinnon, R. Structural basis of PIP2 activation of the classical inward rectifier K+ channel Kir2.2. Nature 477, 495\u2013498 (2011).","journal-title":"Nature"},{"key":"387_CR45","doi-asserted-by":"publisher","first-page":"10500","DOI":"10.1074\/jbc.M208413200","volume":"278","author":"D Schulze","year":"2003","unstructured":"Schulze, D., Krauter, T., Fritzenschaft, H., Soom, M. & Baukrowitz, T. Phosphatidylinositol 4,5-bisphosphate (PIP2) modulation of ATP and pH sensitivity in Kir channels. A tale of an active and a silent PIP2 site in the N terminus. J. Biol. Chem. 278, 10500\u201310505 (2003).","journal-title":"J. Biol. Chem."},{"key":"387_CR46","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.yjmcc.2014.07.012","volume":"75","author":"L Xie","year":"2014","unstructured":"Xie, L. et al. Phosphatidylinositol 4,5-biphosphate (PIP2) modulates syntaxin-1A binding to sulfonylurea receptor 2A to regulate cardiac ATP-sensitive potassium (KATP) channels. J. Mol. Cell Cardiol. 75, 100\u2013110 (2014).","journal-title":"J. Mol. Cell Cardiol."},{"key":"387_CR47","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1113\/JP273274","volume":"595","author":"I Salzer","year":"2017","unstructured":"Salzer, I. et al. Phosphorylation regulates the sensitivity of voltage-gated. Kv7.2 channels towards phosphatidylinositol-4,5-bisphosphate. J. Physiol. 595, 759\u20136 (2017).","journal-title":"J. Physiol."},{"key":"387_CR48","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.bbalip.2017.12.009","volume":"1863","author":"JJ De Jes\u00fas-P\u00e9rez","year":"2018","unstructured":"De Jes\u00fas-P\u00e9rez, J. J. et al. Phosphatidylinositol 4,5-bisphosphate, cholesterol, and fatty acids modulate the calcium-activated chloride channel TMEM16A (ANO1). Biochim Biophys. Acta Mol. Cell Biol. Lipids 1863, 299\u2013312 (2018).","journal-title":"Biochim Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"387_CR49","doi-asserted-by":"publisher","first-page":"10087","DOI":"10.1074\/jbc.M117.785154","volume":"292","author":"S Wang","year":"2017","unstructured":"Wang, S., Borschel, W. F., Heyman, S., Hsu, P. & Nichols, C. G. Conformational changes at cytoplasmic intersubunit interactions control Kir channel gating. J. Biol. Chem. 292, 10087\u201310096 (2017).","journal-title":"J. Biol. Chem."},{"key":"387_CR50","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1073\/pnas.95.3.1307","volume":"95","author":"JL Sui","year":"1998","unstructured":"Sui, J. L., Petit-Jacques, J. & Logothetis, D. E. Activation of the atrial KACh channel by the betagamma subunits of G proteins or intracellular Na+ ions depends on the presence of phosphatidylinositol phosphates. Proc. Natl Acad. Sci. USA 95, 1307\u20131312 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"387_CR51","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/nature01118","volume":"419","author":"L Wu","year":"2002","unstructured":"Wu, L., Bauer, C. S., Zhen, X. G., Xie, C. & Yang, J. Dual regulation of voltage-gated calcium channels by PtdIns(4,5)P. Nature 419, 947\u2013952 (2002).","journal-title":"Nature"},{"key":"387_CR52","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00424-016-1916-4","volume":"469","author":"OV Povstyan","year":"2017","unstructured":"Povstyan, O. V., Barrese, V., Stott, J. B. & Greenwood, I. A. Synergistic interplay of G\u03b2\u03b3 and phosphatidylinositol 4,5-bisphosphate dictates Kv7.4 channel activity. Pflug. Arch. 469, 213\u2013223 (2017).","journal-title":"Pflug. Arch."},{"key":"387_CR53","doi-asserted-by":"publisher","first-page":"6850","DOI":"10.1073\/pnas.110035297","volume":"97","author":"C Saunders","year":"2000","unstructured":"Saunders, C. et al. Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism. Proc. Natl Acad. Sci. USA 97, 6850\u20136855 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"387_CR54","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1046\/j.1471-4159.2002.01133.x","volume":"83","author":"JM Gulley","year":"2002","unstructured":"Gulley, J. M., Doolen, S. & Zahniser, N. R. Brief, repeated exposure to substrates down-regulates dopamine transporter function in Xenopus oocytes in vitro and rat dorsal striatum in vivo. J. Neurochem. 83, 400\u2013411 (2002).","journal-title":"J. Neurochem."},{"key":"387_CR55","doi-asserted-by":"crossref","first-page":"E7138","DOI":"10.1073\/pnas.1511670112","volume":"112","author":"DS Wheeler","year":"2015","unstructured":"Wheeler, D. S. et al. Amphetamine activates Rho GTPase signaling to mediate dopamine transporter internalization and acute behavioral effects of amphetamine. Proc. Natl Acad. Sci. USA 112, E7138\u2013E7147 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"387_CR56","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.mcn.2008.06.011","volume":"39","author":"E Boudanova","year":"2008","unstructured":"Boudanova, E., Navaroli, D. M., Stevens, Z. & Melikian, H. E. Dopamine transporter endocytic determinants: carboxy terminal residues critical for basal and PKC-stimulated internalization. Mol. Cell Neurosci. 39, 211\u2013217 (2008).","journal-title":"Mol. Cell Neurosci."},{"key":"387_CR57","doi-asserted-by":"publisher","first-page":"13758","DOI":"10.1523\/JNEUROSCI.2649-11.2011","volume":"31","author":"DM Navaroli","year":"2011","unstructured":"Navaroli, D. M. et al. The plasma membrane-associated GTPase Rin interacts with the dopamine transporter and is required for protein kinase C-regulated dopamine transporter trafficking. J. Neurosci. 31, 13758\u201313770 (2011).","journal-title":"J. Neurosci."},{"key":"387_CR58","doi-asserted-by":"publisher","first-page":"17836","DOI":"10.1523\/JNEUROSCI.3284-13.2013","volume":"33","author":"LR Gabriel","year":"2013","unstructured":"Gabriel, L. R. et al. Dopamine transporter endocytic trafficking in striatal dopaminergic neurons: differential dependence on dynamin and the actin cytoskeleton. J. Neurosci. 33, 17836\u201317846 (2013).","journal-title":"J. Neurosci."},{"key":"387_CR59","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/pch\/pxx084","volume":"22","author":"ME Feldman","year":"2017","unstructured":"Feldman, M. E. Amphetamine for attention deficit hyperactivity disorder in children and adolescents. Paediatr. Child Health 22, 288\u2013289 (2017).","journal-title":"Paediatr. Child Health"},{"key":"387_CR60","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.4088\/JCP.08m04605","volume":"70","author":"LM Koran","year":"2009","unstructured":"Koran, L. M., Aboujaoude, E. & Gamel, N. N. Double-blind study of dextroamphetamine versus caffeine augmentation for treatment-resistant obsessive-compulsive disorder. J. Clin. Psychiatry 70, 1530\u20131535 (2009).","journal-title":"J. Clin. Psychiatry"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-019-0387-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-019-0387-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-019-0387-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T15:28:10Z","timestamp":1671204490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-019-0387-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,11]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["387"],"URL":"https:\/\/doi.org\/10.1038\/s41398-019-0387-8","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,11]]},"assertion":[{"value":"7 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"81"}}